NovoCure (NVCR) Total Current Liabilities (2014 - 2026)
NovoCure recorded quarterly Total Current Liabilities of $217.6 million in Q1 2026, down 2.53% quarter-over-quarter from $223.2 million in Q4 2025, and down 70.73% year-over-year from $743.3 million in Q1 2025.
NovoCure's Total Current Liabilities history runs 13 years deep, the most recent figure standing at $217.6 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 70.73% year-over-year to $217.6 million; the TTM figure through Mar 2026 stood at $217.6 million (down 70.73% YoY), while the FY2025 annual figure was $223.2 million, down 70.49% from the prior year.
- Total Current Liabilities came in at $217.6 million for Q1 2026 at NovoCure, down from $223.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $776.0 million in Q3 2025 to a low of $127.8 million in Q1 2022.
- A 5-year average of $337.0 million and a median of $169.2 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 367.67% in 2024 and tumbled 70.73% in 2026, its largest moves.
- NovoCure's Total Current Liabilities stood at $158.8 million in 2022, then advanced by 12.81% to $179.1 million in 2023, then surged by 322.3% to $756.4 million in 2024, then slumped by 70.49% to $223.2 million in 2025, then declined by 2.53% to $217.6 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $217.6 million, $223.2 million, and $776.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.15 Bn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 217.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 217.58 Mn |
| Dec 31, 2025 | 223.23 Mn |
| Sep 30, 2025 | 776.01 Mn |
| Jun 30, 2025 | 749.63 Mn |
| Mar 31, 2025 | 743.31 Mn |
| Dec 31, 2024 | 756.39 Mn |
| Sep 30, 2024 | 735.00 Mn |
| Jun 30, 2024 | 169.18 Mn |
| Mar 31, 2024 | 160.23 Mn |
| Dec 31, 2023 | 179.12 Mn |
| Sep 30, 2023 | 157.16 Mn |
| Jun 30, 2023 | 150.09 Mn |
| Mar 31, 2023 | 148.78 Mn |
| Dec 31, 2022 | 158.78 Mn |
| Sep 30, 2022 | 141.08 Mn |
| Jun 30, 2022 | 135.40 Mn |
| Mar 31, 2022 | 127.80 Mn |
| Dec 31, 2021 | 142.60 Mn |
| Sep 30, 2021 | 124.55 Mn |
| Jun 30, 2021 | 116.21 Mn |
| Mar 31, 2021 | 110.49 Mn |
| Dec 31, 2020 | 113.61 Mn |
| Sep 30, 2020 | 95.33 Mn |
| Jun 30, 2020 | 85.12 Mn |
| Mar 31, 2020 | 84.20 Mn |
| Dec 31, 2019 | 86.31 Mn |
| Sep 30, 2019 | 80.41 Mn |
| Jun 30, 2019 | 73.57 Mn |
| Mar 31, 2019 | 70.95 Mn |
| Dec 31, 2018 | 64.56 Mn |
| Sep 30, 2018 | 48.09 Mn |
| Jun 30, 2018 | 45.25 Mn |
| Mar 31, 2018 | 44.76 Mn |
| Dec 31, 2017 | 50.20 Mn |
| Sep 30, 2017 | 40.99 Mn |
| Jun 30, 2017 | 35.17 Mn |
| Mar 31, 2017 | 31.92 Mn |
| Dec 31, 2016 | 36.88 Mn |
| Sep 30, 2016 | 29.71 Mn |
| Jun 30, 2016 | 34.62 Mn |
| Mar 31, 2016 | 29.43 Mn |
| Dec 31, 2015 | 28.63 Mn |
| Sep 30, 2015 | 25.92 Mn |
| Dec 31, 2014 | 17.67 Mn |